Evidence map›Paper›PMID 40953483›Full record

ArticleAnalytical chemistry2025

Hydrogel-Bead Particles Enable Activity-Based Identification of Nucleic Acid Aptamer Enzyme Inhibitors.

Amanda A Nguyen, Brian M Paegel

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amanda A NguyenDepartment of Pharmaceutical Sciences, University of California, Irvine, California 92697, United States.ORCID 0009-0003-9497-7575
Brian M PaegelDepartment of Pharmaceutical Sciences, University of California, Irvine, California 92697, United States.ORCID 0000-0002-6531-6693

Funding

Activity-Based DNA-Encoded Library TechnologyR35GM140890 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Brian M Paegel · 2021 to 2026
$2.2M
NIGMS NIH HHS R35 GM140890
6 · The paper itself

Abstract

Nucleic acid aptamers bridge the gap between small molecules and antibodies as potentially nonimmunogenic, stable, selective, and potent ligands. Aptamer discovery starts with massively parallel affinity selection-driven directed evolution, which only identifies sequences based on target binding. We have developed an activity-based aptamer screening system using magnetic beads templated with aptamer-encoding DNAs and encapsulated in polyacrylamide hydrogel droplets. Magnetic bead-bound DNAs are copied to the oligonucleotide-functionalized gel periphery via transcription-reverse transcription amplification. A model enzyme (trypsin) in-gel activity assay was developed wherein tryptic hydrolysis of a gel-immobilized N-terminal-Cy5-labeled trypsin substrate peptide is inhibited in the presence of gel-immobilized trypsin inhibitor aptamers, leaving the bead with high Cy5 fluorescence for sorting. Proof-of-concept screens enriched positive controls 100,000-fold in multiround screens. Though this study used DNA, the technology could also be applied to non-natural nucleic acids and other encoded library formats.

Indexed as

Aptamers, NucleotideHydrogelsTrypsin InhibitorsTrypsinAptamers, NucleotideHydrogelsTrypsinTrypsin Inhibitors

Identifiers

PMID40953483
PMCPMC13091754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.